The DIVERSA project was born from the need to find effective treatments for diseases for which there is either no treatment or it is not effective. It bases his work on improving the initial research process for drugs and treatments, where the vast majority of molecules studied (potentially effective) are discarded as they cannot be transported to their place of action, inside the cell.

At DIVERSA, with its patented technology, nano-sized lipid emulsions transport these molecules to their place of action so that they are effective and generate opportunities for the development of new and more effective treatments.

Its platform is the most versatile and simple on the current market, fully compatible with industrial and regulatory scaling, and with a very high translationality to therapeutic use, with high potential to become a reference in research processes of the intracellular mechanism and therapeutic potential of biomolecules. (proteins, peptides, aptamers, antibodies, DNA or RNA) or hydrophobic small molecules.